Annual CFF
-$883.00 K
-$224.49 M-100.39%
December 31, 2023
Summary
- As of February 7, 2025, AUTL annual cash flow from financing activities is -$883.00 thousand, with the most recent change of -$224.49 million (-100.39%) on December 31, 2023.
- During the last 3 years, AUTL annual CFF has fallen by -$75.30 million (-101.19%).
- AUTL annual CFF is now -100.31% below its all-time high of $284.06 million, reached on December 31, 2021.
Performance
AUTL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$185.00 K
+$2.26 M+108.90%
September 30, 2024
Summary
- As of February 7, 2025, AUTL quarterly cash flow from financing activities is $185.00 thousand, with the most recent change of +$2.26 million (+108.90%) on September 30, 2024.
- Over the past year, AUTL quarterly CFF has dropped by -$561.26 million (-99.97%).
- AUTL quarterly CFF is now -99.97% below its all-time high of $561.44 million, reached on March 31, 2024.
Performance
AUTL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$559.57 M
+$181.00 K+0.03%
September 30, 2024
Summary
- As of February 7, 2025, AUTL TTM cash flow from financing activities is $559.57 million, with the most recent change of +$181.00 thousand (+0.03%) on September 30, 2024.
- Over the past year, AUTL TTM CFF has dropped by -$1.68 million (-0.30%).
- AUTL TTM CFF is now -0.30% below its all-time high of $561.25 million, reached on March 31, 2024.
Performance
AUTL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AUTL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.4% | -100.0% | -0.3% |
| 3 y3 years | -101.2% | +184.5% | +151.3% |
| 5 y5 years | -100.0% | +184.5% | +151.3% |
AUTL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.3% | at low | -100.0% | +108.9% | -0.3% | >+9999.0% |
| 5 y | 5-year | -100.3% | at low | -100.0% | +108.9% | -0.3% | >+9999.0% |
| alltime | all time | -100.3% | at low | -100.0% | +108.9% | -0.3% | >+9999.0% |
Autolus Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $185.00 K(-108.9%) | $559.57 M(+0.0%) |
| Jun 2024 | - | -$2.08 M(-100.4%) | $559.39 M(-0.3%) |
| Mar 2024 | - | $561.44 M(>+9900.0%) | $561.25 M(<-9900.0%) |
| Dec 2023 | -$883.00 K(-100.4%) | $23.00 K(+475.0%) | -$883.00 K(-100.4%) |
| Sep 2023 | - | $4000.00(-101.8%) | $222.60 M(-0.0%) |
| Jun 2023 | - | -$219.00 K(-68.3%) | $222.70 M(-0.1%) |
| Mar 2023 | - | -$691.00 K(-100.3%) | $222.92 M(-0.3%) |
| Dec 2022 | $223.61 M(-21.3%) | $223.51 M(>+9900.0%) | $223.61 M(+51.6%) |
| Sep 2022 | - | $102.00 K(>+9900.0%) | $147.52 M(+0.2%) |
| Jun 2022 | - | $0.00(-100.0%) | $147.18 M(-8.4%) |
| Mar 2022 | - | -$1000.00(-100.0%) | $160.74 M(-43.4%) |
| Dec 2021 | $284.06 M | $147.41 M(<-9900.0%) | $284.06 M(+107.3%) |
| Sep 2021 | - | -$230.00 K(-101.7%) | $137.04 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $13.55 M(-89.0%) | $137.28 M(+11.2%) |
| Mar 2021 | - | $123.32 M(>+9900.0%) | $123.43 M(+65.9%) |
| Dec 2020 | $74.42 M(-31.6%) | $392.00 K(+3820.0%) | $74.42 M(+0.5%) |
| Sep 2020 | - | $10.00 K(-103.4%) | $74.06 M(+0.8%) |
| Jun 2020 | - | -$297.00 K(-100.4%) | $73.47 M(-59.9%) |
| Mar 2020 | - | $74.31 M(>+9900.0%) | $183.17 M(+68.3%) |
| Dec 2019 | $108.86 M(>+9900.0%) | $34.00 K(-105.9%) | $108.86 M(+0.0%) |
| Sep 2019 | - | -$576.00 K(-100.5%) | $108.83 M(-0.5%) |
| Jun 2019 | - | $109.40 M(>+9900.0%) | $109.41 M(>+9900.0%) |
| Mar 2019 | - | $4000.00 | $4000.00 |
| Dec 2018 | $0.00(-100.0%) | - | - |
| Sep 2018 | $156.92 M(+22.9%) | - | - |
| Sep 2017 | $127.69 M(+296.3%) | - | - |
| Sep 2016 | $32.22 M | - | - |
FAQ
- What is Autolus Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Autolus Therapeutics?
- What is Autolus Therapeutics annual CFF year-on-year change?
- What is Autolus Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Autolus Therapeutics?
- What is Autolus Therapeutics quarterly CFF year-on-year change?
- What is Autolus Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Autolus Therapeutics?
- What is Autolus Therapeutics TTM CFF year-on-year change?
What is Autolus Therapeutics annual cash flow from financing activities?
The current annual CFF of AUTL is -$883.00 K
What is the all time high annual CFF for Autolus Therapeutics?
Autolus Therapeutics all-time high annual cash flow from financing activities is $284.06 M
What is Autolus Therapeutics annual CFF year-on-year change?
Over the past year, AUTL annual cash flow from financing activities has changed by -$224.49 M (-100.39%)
What is Autolus Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of AUTL is $185.00 K
What is the all time high quarterly CFF for Autolus Therapeutics?
Autolus Therapeutics all-time high quarterly cash flow from financing activities is $561.44 M
What is Autolus Therapeutics quarterly CFF year-on-year change?
Over the past year, AUTL quarterly cash flow from financing activities has changed by -$561.26 M (-99.97%)
What is Autolus Therapeutics TTM cash flow from financing activities?
The current TTM CFF of AUTL is $559.57 M
What is the all time high TTM CFF for Autolus Therapeutics?
Autolus Therapeutics all-time high TTM cash flow from financing activities is $561.25 M
What is Autolus Therapeutics TTM CFF year-on-year change?
Over the past year, AUTL TTM cash flow from financing activities has changed by -$1.68 M (-0.30%)